MPDL Ltd (532723)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.38 offers an apparent discount: ₹38.40 market price versus ₹102.19 book value per share.
• Market cap is small at ₹28 Cr, which can be a fertile space for under-researched asset situations.
• The company still has a revenue base of ₹2 Cr in the latest quarter, implying some operating activity and project life.
• 52-week low of ₹29.42 suggests the current price is not chasing a speculative high, though that alone is not a bullish sign.

Concerns

• Earnings are firmly negative: ROE -6.97%, ROCE -2.87%, and latest quarterly net profit of -₹1 Cr on ₹2 Cr sales.
• Profit growth of -106.52% and sales decline of -4.33% show erosion, not recovery.
• Piotroski F-Score of 2/9 reflects very poor financial health and limited fundamental improvement.
• Missing data on debt/equity and promoter holding prevents any real assessment of financial risk and insider alignment.

AI Analysis

When I see a stock at ₹38.40 against a book value of ₹102.19, my reflexes say 'Graham would want to look closer.' But value is not a number on a balance sheet; it is the ability of the business to earn a good return on that book over time. MPDL fails this test today. Return on equity is -6.97%, and return on capital employed is -2.87%. The latest quarter reported sales of just ₹2 Cr and a net loss of ₹1 Cr; the 52-week range suggests an in-between, beaten-down price. Sales growth is -4.33% and profit growth -106.52%, so the earnings engine is going backwards. The Piotroski F-Score of 2/9 is a red flag, not a beacon. You cannot value this with a P/E because there is no positive 'E' to put in the denominator. So why am I still interested? Because the market cap is ₹28 Cr, less than 38 paise per rupee of stated book value. In Indian real estate, book value can be stale, overstated, or tied up in slow-moving projects, and I have no information on debt, promoter holding, or asset quality. This is not a stalwart. It is a distressed asset play where the margin of safety depends entirely on whether the underlying land and projects are worth more than the market believes. If management can sell, develop, or unlock that book value, the upside is obvious. If not, the book value will disintegrate through losses. I would want far more disclosure, and a plan, before deploying even a small amount of patient capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer